(Q33367688)

26 July 2017

1 reference

title

The therapeutic application of melatonin in supportive care and palliative medicine (English)

1 reference

26 July 2017

0 references

Fade Mahmoud

1

1 reference

26 July 2017

Nabeel Sarhill

series ordinal

2

1 reference

26 July 2017

Miroslaw A Mazurczak

series ordinal

3

1 reference

26 July 2017

publication date

1 July 2005

1 reference

American Journal of Hospice and Palliative Medicine

26 July 2017

published in

1 reference

26 July 2017

volume

22

1 reference

26 July 2017

issue

4

1 reference

26 July 2017

page(s)

295-309

1 reference

Effect of tryptophan administration on circulating melatonin levels in chicks and rats: evidence for stimulation of melatonin synthesis and release in the gastrointestinal tract

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200412

Regulation of the mammalian pineal by non-rod, non-cone, ocular photoreceptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200412

Photic regulation of melatonin in humans: ocular and neural signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200412

Melatonin high-affinity binding to alpha-1-acid glycoprotein in human serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200412

The correlation between serum and salivary melatonin concentrations and urinary 6-hydroxymelatonin sulphate excretion rates: two non-invasive techniques for monitoring human circadian rhythmicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200412

Pharmacokinetics of melatonin in man: first pass hepatic metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200412

Putative melatonin receptors in a human biological clock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200412

Evidence for modulation of melatonin secretion in men with benign and malignant tumors of the prostate: relationship with the pituitary hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200412

Rotating night shifts and risk of breast cancer in women participating in the nurses' health study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200412

Night-shift work and risk of colorectal cancer in the nurses' health study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200412

Mitotic arrest by melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200412

Effects of melatonin on the proliferation and differentiation of human neuroblastoma cells in culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200412

Antitumor activity of the pineal gland: effect of unidentified substances versus the effect of melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200412

Efficacy of the concomitant administration of the pineal hormone melatonin in cancer immunotherapy with low-dose IL-2 in patients with advanced solid tumors who had progressed on IL-2 alone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200412

Immunotherapy with subcutaneous low-dose interleukin-2 and the pineal indole melatonin as a new effective therapy in advanced cancers of the digestive tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200412

Modulation of human lymphoblastoid interferon activity by melatonin in metastatic renal cell carcinoma. A phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200412

Decreased toxicity and increased efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solid tumour patients with poor clinical status

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200412

Nocturnal urinary 6-sulfatoxymelatonin and proliferating cell nuclear antigen-immunopositive tumor cells show strong positive correlations in patients with gastrointestinal and lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200412

Serum melatonin levels following enucleation and transpupillary thermotherapy in patients with choroidal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200412

Adjuvant therapy with the pineal hormone melatonin in patients with lymph node relapse due to malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200412

Melatonin reduces interleukin secretion in amyloid-beta stressed mouse brain slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200412

Randomized study with the pineal hormone melatonin versus supportive care alone in advanced nonsmall cell lung cancer resistant to a first-line chemotherapy containing cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200412

Increased survival time in brain glioblastomas by a radioneuroendocrine strategy with radiotherapy plus melatonin compared to radiotherapy alone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200412

Evaluation of the antioxidant activity of melatonin in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200412

Melatonin, hydroxyl radical-mediated oxidative damage, and aging: a hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200412

Melatonin stimulates brain glutathione peroxidase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200412

Nitrosation of melatonin by nitric oxide and peroxynitrite

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200412

Inhibition of cerebellar nitric oxide synthase and cyclic GMP production by melatonin via complex formation with calmodulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200412

Pineal-opioid system interactions in the control of immunoinflammatory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200412

The immunoneuroendocrine role of melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200412

Modulation of cancer endocrine therapy by melatonin: a phase II study of tamoxifen plus melatonin in metastatic breast cancer patients progressing under tamoxifen alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200412

Melatonin, immune modulation and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200412

A randomized study with the pineal hormone melatonin versus supportive care alone in patients with brain metastases due to solid neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200412

Melatonin rhythmicity: effect of age and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200412

Sleep-inducing effects of low doses of melatonin ingested in the evening

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200412

Sleep laboratory investigations on hypnotic properties of melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200412

Premedication with melatonin: a double-blind, placebo-controlled comparison with midazolam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200412

Melatonin in elderly patients with insomnia. A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200412

The use of melatonin for the treatment of insomnia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200412

Melatonin: therapeutic use in sleep disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200412

Neuroendocrine probes as biological markers of affective disorders: new directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200412

Nocturnal serum melatonin profile in major depression in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200412

Melatonin, cortisol and ACTH in patients with major depressive disorder and healthy humans with special reference to the outcome of the dexamethasone suppression test

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200412

Differences in nocturnal melatonin secretion between melancholic depressed patients and control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200412

A Biological Study on the Efficacy of Low–Dose Subcutaneous lnterleukin–2 plus Melatonin in the Treatment of Cancer–Related Thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200412

Chemoneuroendocrine therapy of metastatic breast cancer with persistent thrombocytopenia with weekly low-dose epirubicin plus melatonin: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200412

Randomized, double-blind clinical trial, controlled with placebo, of the toxicology of chronic melatonin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200412

A phase II study of tamoxifen plus melatonin in metastatic solid tumour patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200412

The symptoms of advanced cancer: relationship to age, gender, and performance status in 1,000 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200412

A randomized study of neuroimmunotherapy with low-dose subcutaneous interleukin-2 plus melatonin compared to supportive care alone in patients with untreatable metastatic solid tumour.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200412

Biological and clinical results of a neuroimmunotherapy with interleukin-2 and the pineal hormone melatonin as a first line treatment in advanced non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200412

10.1177/104990910502200412

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference